• Mubritinib (TAK 165) in Cancer Research: Protocols and Pitfa

  2026-07-14

  Mubritinib (TAK 165) unlocks new frontiers in targeting oxidative phosphorylation dependency in chemotherapy-resistant acute myeloid leukemia and KSHV-positive lymphoma models. This guide delivers practical, evidence-backed workflows, troubleshooting strategies, and cross-domain insights for maximizing assay impact.

• Lamotrigine in Cardiotoxicity Screening: Beyond Epilepsy Mod

  2026-07-13

  Explore how Lamotrigine, a sodium channel blocker and 5-HT inhibitor, advances cardiotoxicity screening using iPSC-derived cardiomyocytes. This article uniquely bridges molecular pharmacology and translational assay design, offering practical insights distinct from standard epilepsy research applications.

• Remdesivir (GS-5734): Optimizing Antiviral Workflows in RNA

  2026-07-13

  Remdesivir (GS-5734) stands out as a benchmark tool for evaluating RNA virus replication, offering robust potency against coronaviruses and filoviruses. This article delivers practical guidance on experimental workflows, troubleshooting strategies, and integration of new structural insights for targeted antiviral discovery.

• JNK-IN-7: Selective JNK Inhibitor in Apoptosis and MAPK Rese

  2026-07-12

  JNK-IN-7 empowers researchers to dissect JNK-driven apoptosis and innate immune signaling with unmatched selectivity and covalent inhibition. This guide translates recent breakthroughs into actionable workflows, troubleshooting strategies, and advanced protocol enhancements for MAPK pathway and Toll receptor signaling studies.

• Berberrubine Inhibits Thrombosis via Vitamin K Cycle Modulat

  2026-07-10

  This study reveals that berberrubine, a key berberine metabolite, suppresses thrombosis in mice by targeting the vitamin K catalytic cycle. Integrated metabolomics and molecular docking provide mechanistic insights, offering a potential avenue for developing safer antithrombotic agents.

• Anti Reverse Cap Analog (ARCA): Optimizing mRNA Therapeutics

  2026-07-09

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, drives next-generation mRNA therapeutics through precise capping and enhanced translation. Discover mechanistic insights and translational applications beyond conventional workflow guides.

• Salmonella Haem Biosynthesis Drives Macrophage Evasion

  2026-07-09

  This study reveals that Salmonella Typhimurium resists macrophage phagocytosis via methyltransferase-mediated upregulation of haem biosynthesis. These findings clarify how pathogen-derived haem suppresses innate immunity and enhance our understanding of bacterial virulence mechanisms.

• Stiripentol as an LDH Inhibitor: Bridging Epilepsy and Immun

  2026-07-08

  Explore how Stiripentol, a potent LDH inhibitor, enables advanced research into epilepsy and immunometabolism by modulating the astrocyte-neuron lactate shuttle. This deep dive reveals novel assay strategies and practical insights beyond existing guides.

• Bazedoxifene in Translational Bone Research: Mechanisms and

  2026-07-08

  Explore Bazedoxifene, a selective estrogen receptor modulator, with a focus on translational bone research, mechanistic insights, and advanced assay design. This article offers evidence-based guidance distinct from existing reviews.

• ddhCTP: Advanced Strategies for Antiviral Assay Design

  2026-07-07

  Explore how ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) enables precise, mechanism-guided antiviral assay development. This article delivers a deeper look at ddhCTP’s role in RNA virus replication inhibition and practical experimental workflows.

• Excessive Calpain Disrupts Offspring Cognition via BDNF/TrkB

  2026-07-07

  This study demonstrates that excessive calpain activation after maternal non-obstetric surgery impairs cognitive development in offspring by disrupting BDNF/TrkB signaling and hippocampal structure. Pharmacological calpain inhibition with MDL 28170 or TrkB activation partially restores neuronal integrity, offering mechanistic insight and translational strategies for neuroprotection.

• Mubritinib (TAK 165): Applied Protocols for Cancer Research

  2026-07-06

  Mubritinib (TAK 165) is transforming cancer biology and virology research by enabling precise mitochondrial complex I inhibition and selective cytotoxicity in challenging disease models. This article delivers actionable workflows, troubleshooting insights, and evidence-driven protocol guidance for researchers harnessing Mubritinib’s unique dual activity.

• Degarelix Acetate: Precision GnRH Receptor Antagonism in Res

  2026-07-06

  Degarelix acetate offers bench scientists a highly selective, rapid, and reproducible tool for probing GnRH receptor-driven hormone pathways. This guide distills protocol enhancements, troubleshooting insights, and translational use-cases—anchored in emerging synthesis and assay methodologies—to maximize experimental clarity and reliability.

• Applied Workflows with BET Bromodomain Inhibitor (+)-JQ1

  2026-07-05

  BET bromodomain inhibitor (+)-JQ1 unlocks powerful, reproducible workflows for apoptosis, inflammation, and reproductive biology. This guide details stepwise methods, protocol parameters, and troubleshooting tips to maximize its value in translational and cancer research.

• RNAi Screen Reveals Vesicular Transport in SARS-CoV-2 Releas

  2026-07-04

  Kerr et al. present a genome-scale RNA interference screen that uncovers vesicle-mediated exocytic transport, particularly Rab11a-dependent pathways, as crucial for SARS-CoV-2 release from human cells. Their validation that CDK9 inhibition blocks viral egress highlights new avenues for host-targeted antiviral development.

444 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page